About Index Trending news
Lists
Pricing
Bavarian Nordic

Bavarian Nordic

Bavarian Nordic

Bavarian Nordic (OMX:$BAVA, OTC:$BVNRY) develops cancer immunotherapies and vaccines against infectious diseases

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO debt
$50,000,000
Post-IPO debt
$55,874,661
Employees

Unknown size

Locations
HQ
Headquarters
$50,000,000 Post-IPO debt
BioPortfolio

Bavarian Nordic Granted EUR 50 Million Loan from The European Investment Bank